Cerevast Therapeutics Secures $1,479,154 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ea8aa905-bd1b-42f8-bf03-6b3652523266&Preview=1 - Date
4/22/2013 - Company Name
Cerevast Therapeutics - Mailing Address
12277 134th Court NE Redmond, WA 98052 - Company Description
Cerevast Therapeutics, Inc. is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders. - Website
http://www.cerevast.com - Transaction Type
Venture Equity - Transaction Amount
$1,479,154 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
